Medical Care
Global Gene Therapies for Cancer Treatment Market Research Report 2025
- Sep 18, 25
- ID: 508023
- Pages: 83
- Figures: 90
- Views: 24
This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Cancer Treatment.
The Gene Therapies for Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapies for Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapies for Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Segment by Type
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Segment by Application
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Gene Therapies for Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapies for Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapies for Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Segment by Type
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Segment by Application
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Somatic Cell Gene Therapy (SCGT)
1.2.3 Germline Gene Therapy (GGT)
1.3 Market by Application
1.3.1 Global Gene Therapies for Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Cancer Hospitals
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2020-2031)
2.2 Global Gene Therapies for Cancer Treatment Growth Trends by Region
2.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapies for Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapies for Cancer Treatment Market Dynamics
2.3.1 Gene Therapies for Cancer Treatment Industry Trends
2.3.2 Gene Therapies for Cancer Treatment Market Drivers
2.3.3 Gene Therapies for Cancer Treatment Market Challenges
2.3.4 Gene Therapies for Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue
3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapies for Cancer Treatment Revenue
3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2024
3.5 Global Key Players of Gene Therapies for Cancer Treatment Head office and Area Served
3.6 Global Key Players of Gene Therapies for Cancer Treatment, Product and Application
3.7 Global Key Players of Gene Therapies for Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapies for Cancer Treatment Breakdown Data by Type
4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Gene Therapies for Cancer Treatment Breakdown Data by Application
5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapies for Cancer Treatment Market Size (2020-2031)
6.2 North America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapies for Cancer Treatment Market Size (2020-2031)
7.2 Europe Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2020-2031)
9.2 Latin America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takara Bio
11.1.1 Takara Bio Company Details
11.1.2 Takara Bio Business Overview
11.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
11.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.1.5 Takara Bio Recent Development
11.2 Tocagen
11.2.1 Tocagen Company Details
11.2.2 Tocagen Business Overview
11.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
11.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.2.5 Tocagen Recent Development
11.3 VBL Therapeutics
11.3.1 VBL Therapeutics Company Details
11.3.2 VBL Therapeutics Business Overview
11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
11.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.3.5 VBL Therapeutics Recent Development
11.4 Cold Genesys
11.4.1 Cold Genesys Company Details
11.4.2 Cold Genesys Business Overview
11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
11.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.4.5 Cold Genesys Recent Development
11.5 Genprex
11.5.1 Genprex Company Details
11.5.2 Genprex Business Overview
11.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
11.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.5.5 Genprex Recent Development
11.6 Momotaro-Gene
11.6.1 Momotaro-Gene Company Details
11.6.2 Momotaro-Gene Business Overview
11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
11.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.6.5 Momotaro-Gene Recent Development
11.7 MultiVir
11.7.1 MultiVir Company Details
11.7.2 MultiVir Business Overview
11.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
11.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.7.5 MultiVir Recent Development
11.8 SynerGene Therapeutics
11.8.1 SynerGene Therapeutics Company Details
11.8.2 SynerGene Therapeutics Business Overview
11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
11.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.8.5 SynerGene Therapeutics Recent Development
11.9 Ziopharm Oncology
11.9.1 Ziopharm Oncology Company Details
11.9.2 Ziopharm Oncology Business Overview
11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
11.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.9.5 Ziopharm Oncology Recent Development
11.10 Anchiano Therapeutics
11.10.1 Anchiano Therapeutics Company Details
11.10.2 Anchiano Therapeutics Business Overview
11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
11.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.10.5 Anchiano Therapeutics Recent Development
11.11 Celgene
11.11.1 Celgene Company Details
11.11.2 Celgene Business Overview
11.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
11.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.11.5 Celgene Recent Development
11.12 Celsion
11.12.1 Celsion Company Details
11.12.2 Celsion Business Overview
11.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
11.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.12.5 Celsion Recent Development
11.13 Bluebird Bio
11.13.1 Bluebird Bio Company Details
11.13.2 Bluebird Bio Business Overview
11.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
11.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.13.5 Bluebird Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Somatic Cell Gene Therapy (SCGT)
1.2.3 Germline Gene Therapy (GGT)
1.3 Market by Application
1.3.1 Global Gene Therapies for Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Cancer Hospitals
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2020-2031)
2.2 Global Gene Therapies for Cancer Treatment Growth Trends by Region
2.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapies for Cancer Treatment Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapies for Cancer Treatment Market Dynamics
2.3.1 Gene Therapies for Cancer Treatment Industry Trends
2.3.2 Gene Therapies for Cancer Treatment Market Drivers
2.3.3 Gene Therapies for Cancer Treatment Market Challenges
2.3.4 Gene Therapies for Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue
3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2020-2025)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapies for Cancer Treatment Revenue
3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2024
3.5 Global Key Players of Gene Therapies for Cancer Treatment Head office and Area Served
3.6 Global Key Players of Gene Therapies for Cancer Treatment, Product and Application
3.7 Global Key Players of Gene Therapies for Cancer Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapies for Cancer Treatment Breakdown Data by Type
4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2026-2031)
5 Gene Therapies for Cancer Treatment Breakdown Data by Application
5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapies for Cancer Treatment Market Size (2020-2031)
6.2 North America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
6.4 North America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapies for Cancer Treatment Market Size (2020-2031)
7.2 Europe Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2020-2031)
9.2 Latin America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takara Bio
11.1.1 Takara Bio Company Details
11.1.2 Takara Bio Business Overview
11.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
11.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.1.5 Takara Bio Recent Development
11.2 Tocagen
11.2.1 Tocagen Company Details
11.2.2 Tocagen Business Overview
11.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
11.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.2.5 Tocagen Recent Development
11.3 VBL Therapeutics
11.3.1 VBL Therapeutics Company Details
11.3.2 VBL Therapeutics Business Overview
11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
11.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.3.5 VBL Therapeutics Recent Development
11.4 Cold Genesys
11.4.1 Cold Genesys Company Details
11.4.2 Cold Genesys Business Overview
11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
11.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.4.5 Cold Genesys Recent Development
11.5 Genprex
11.5.1 Genprex Company Details
11.5.2 Genprex Business Overview
11.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
11.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.5.5 Genprex Recent Development
11.6 Momotaro-Gene
11.6.1 Momotaro-Gene Company Details
11.6.2 Momotaro-Gene Business Overview
11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
11.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.6.5 Momotaro-Gene Recent Development
11.7 MultiVir
11.7.1 MultiVir Company Details
11.7.2 MultiVir Business Overview
11.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
11.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.7.5 MultiVir Recent Development
11.8 SynerGene Therapeutics
11.8.1 SynerGene Therapeutics Company Details
11.8.2 SynerGene Therapeutics Business Overview
11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
11.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.8.5 SynerGene Therapeutics Recent Development
11.9 Ziopharm Oncology
11.9.1 Ziopharm Oncology Company Details
11.9.2 Ziopharm Oncology Business Overview
11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
11.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.9.5 Ziopharm Oncology Recent Development
11.10 Anchiano Therapeutics
11.10.1 Anchiano Therapeutics Company Details
11.10.2 Anchiano Therapeutics Business Overview
11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
11.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.10.5 Anchiano Therapeutics Recent Development
11.11 Celgene
11.11.1 Celgene Company Details
11.11.2 Celgene Business Overview
11.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
11.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.11.5 Celgene Recent Development
11.12 Celsion
11.12.1 Celsion Company Details
11.12.2 Celsion Business Overview
11.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
11.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.12.5 Celsion Recent Development
11.13 Bluebird Bio
11.13.1 Bluebird Bio Company Details
11.13.2 Bluebird Bio Business Overview
11.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
11.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)
11.13.5 Bluebird Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Somatic Cell Gene Therapy (SCGT)
Table 3. Key Players of Germline Gene Therapy (GGT)
Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Therapies for Cancer Treatment Market Share by Region (2020-2025)
Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Therapies for Cancer Treatment Market Share by Region (2026-2031)
Table 10. Gene Therapies for Cancer Treatment Market Trends
Table 11. Gene Therapies for Cancer Treatment Market Drivers
Table 12. Gene Therapies for Cancer Treatment Market Challenges
Table 13. Gene Therapies for Cancer Treatment Market Restraints
Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2020-2025)
Table 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2024)
Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Therapies for Cancer Treatment, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapies for Cancer Treatment, Product and Application
Table 21. Global Key Players of Gene Therapies for Cancer Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Takara Bio Company Details
Table 47. Takara Bio Business Overview
Table 48. Takara Bio Gene Therapies for Cancer Treatment Product
Table 49. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 50. Takara Bio Recent Development
Table 51. Tocagen Company Details
Table 52. Tocagen Business Overview
Table 53. Tocagen Gene Therapies for Cancer Treatment Product
Table 54. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 55. Tocagen Recent Development
Table 56. VBL Therapeutics Company Details
Table 57. VBL Therapeutics Business Overview
Table 58. VBL Therapeutics Gene Therapies for Cancer Treatment Product
Table 59. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 60. VBL Therapeutics Recent Development
Table 61. Cold Genesys Company Details
Table 62. Cold Genesys Business Overview
Table 63. Cold Genesys Gene Therapies for Cancer Treatment Product
Table 64. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 65. Cold Genesys Recent Development
Table 66. Genprex Company Details
Table 67. Genprex Business Overview
Table 68. Genprex Gene Therapies for Cancer Treatment Product
Table 69. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 70. Genprex Recent Development
Table 71. Momotaro-Gene Company Details
Table 72. Momotaro-Gene Business Overview
Table 73. Momotaro-Gene Gene Therapies for Cancer Treatment Product
Table 74. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 75. Momotaro-Gene Recent Development
Table 76. MultiVir Company Details
Table 77. MultiVir Business Overview
Table 78. MultiVir Gene Therapies for Cancer Treatment Product
Table 79. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 80. MultiVir Recent Development
Table 81. SynerGene Therapeutics Company Details
Table 82. SynerGene Therapeutics Business Overview
Table 83. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product
Table 84. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 85. SynerGene Therapeutics Recent Development
Table 86. Ziopharm Oncology Company Details
Table 87. Ziopharm Oncology Business Overview
Table 88. Ziopharm Oncology Gene Therapies for Cancer Treatment Product
Table 89. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 90. Ziopharm Oncology Recent Development
Table 91. Anchiano Therapeutics Company Details
Table 92. Anchiano Therapeutics Business Overview
Table 93. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product
Table 94. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 95. Anchiano Therapeutics Recent Development
Table 96. Celgene Company Details
Table 97. Celgene Business Overview
Table 98. Celgene Gene Therapies for Cancer Treatment Product
Table 99. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 100. Celgene Recent Development
Table 101. Celsion Company Details
Table 102. Celsion Business Overview
Table 103. Celsion Gene Therapies for Cancer Treatment Product
Table 104. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 105. Celsion Recent Development
Table 106. Bluebird Bio Company Details
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio Gene Therapies for Cancer Treatment Product
Table 109. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 110. Bluebird Bio Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Gene Therapies for Cancer Treatment Picture
Figure 2. Global Gene Therapies for Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapies for Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Somatic Cell Gene Therapy (SCGT) Features
Figure 5. Germline Gene Therapy (GGT) Features
Figure 6. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapies for Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 8. Cancer Research Centers Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Cancer Hospitals Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Therapies for Cancer Treatment Report Years Considered
Figure 13. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Gene Therapies for Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Gene Therapies for Cancer Treatment Market Share by Players in 2024
Figure 17. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2024
Figure 19. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 21. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 25. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2020-2031)
Figure 33. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 49. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 50. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 51. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 52. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 53. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 54. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 55. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 56. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 57. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 58. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 59. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 60. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Somatic Cell Gene Therapy (SCGT)
Table 3. Key Players of Germline Gene Therapy (GGT)
Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Therapies for Cancer Treatment Market Share by Region (2020-2025)
Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Therapies for Cancer Treatment Market Share by Region (2026-2031)
Table 10. Gene Therapies for Cancer Treatment Market Trends
Table 11. Gene Therapies for Cancer Treatment Market Drivers
Table 12. Gene Therapies for Cancer Treatment Market Challenges
Table 13. Gene Therapies for Cancer Treatment Market Restraints
Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2020-2025)
Table 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2024)
Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Therapies for Cancer Treatment, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapies for Cancer Treatment, Product and Application
Table 21. Global Key Players of Gene Therapies for Cancer Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Takara Bio Company Details
Table 47. Takara Bio Business Overview
Table 48. Takara Bio Gene Therapies for Cancer Treatment Product
Table 49. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 50. Takara Bio Recent Development
Table 51. Tocagen Company Details
Table 52. Tocagen Business Overview
Table 53. Tocagen Gene Therapies for Cancer Treatment Product
Table 54. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 55. Tocagen Recent Development
Table 56. VBL Therapeutics Company Details
Table 57. VBL Therapeutics Business Overview
Table 58. VBL Therapeutics Gene Therapies for Cancer Treatment Product
Table 59. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 60. VBL Therapeutics Recent Development
Table 61. Cold Genesys Company Details
Table 62. Cold Genesys Business Overview
Table 63. Cold Genesys Gene Therapies for Cancer Treatment Product
Table 64. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 65. Cold Genesys Recent Development
Table 66. Genprex Company Details
Table 67. Genprex Business Overview
Table 68. Genprex Gene Therapies for Cancer Treatment Product
Table 69. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 70. Genprex Recent Development
Table 71. Momotaro-Gene Company Details
Table 72. Momotaro-Gene Business Overview
Table 73. Momotaro-Gene Gene Therapies for Cancer Treatment Product
Table 74. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 75. Momotaro-Gene Recent Development
Table 76. MultiVir Company Details
Table 77. MultiVir Business Overview
Table 78. MultiVir Gene Therapies for Cancer Treatment Product
Table 79. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 80. MultiVir Recent Development
Table 81. SynerGene Therapeutics Company Details
Table 82. SynerGene Therapeutics Business Overview
Table 83. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product
Table 84. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 85. SynerGene Therapeutics Recent Development
Table 86. Ziopharm Oncology Company Details
Table 87. Ziopharm Oncology Business Overview
Table 88. Ziopharm Oncology Gene Therapies for Cancer Treatment Product
Table 89. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 90. Ziopharm Oncology Recent Development
Table 91. Anchiano Therapeutics Company Details
Table 92. Anchiano Therapeutics Business Overview
Table 93. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product
Table 94. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 95. Anchiano Therapeutics Recent Development
Table 96. Celgene Company Details
Table 97. Celgene Business Overview
Table 98. Celgene Gene Therapies for Cancer Treatment Product
Table 99. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 100. Celgene Recent Development
Table 101. Celsion Company Details
Table 102. Celsion Business Overview
Table 103. Celsion Gene Therapies for Cancer Treatment Product
Table 104. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 105. Celsion Recent Development
Table 106. Bluebird Bio Company Details
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio Gene Therapies for Cancer Treatment Product
Table 109. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)
Table 110. Bluebird Bio Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Gene Therapies for Cancer Treatment Picture
Figure 2. Global Gene Therapies for Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapies for Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Somatic Cell Gene Therapy (SCGT) Features
Figure 5. Germline Gene Therapy (GGT) Features
Figure 6. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapies for Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 8. Cancer Research Centers Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Cancer Hospitals Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Therapies for Cancer Treatment Report Years Considered
Figure 13. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Gene Therapies for Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Gene Therapies for Cancer Treatment Market Share by Players in 2024
Figure 17. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2024
Figure 19. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 21. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 25. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2020-2031)
Figure 33. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 49. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 50. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 51. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 52. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 53. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 54. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 55. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 56. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 57. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 58. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 59. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 60. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232